These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1794582)

  • 1. Cholecystokinin receptors: synthetic antagonists with selectivity for receptor subtypes and possible clinical applications.
    Iversen LL; Dourish CT; Iversen SD
    Biochem Soc Trans; 1991 Nov; 19(4):913-5. PubMed ID: 1794582
    [No Abstract]   [Full Text] [Related]  

  • 2. CCK receptor antagonists.
    Dunlop J
    Gen Pharmacol; 1998 Oct; 31(4):519-24. PubMed ID: 9792209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of cholecystokinin (CCK) receptor antagonists, MK-329 and L-365,260, for axonally-transported CCK binding sites on the rat vagus nerve.
    Mercer JG; Lawrence CB
    Neurosci Lett; 1992 Mar; 137(2):229-31. PubMed ID: 1374868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular design of potent specific antagonists for the gastrin and cholecystokinin receptors.
    Evans BE
    Z Gastroenterol Verh; 1991 Mar; 26():269-71. PubMed ID: 1714170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of morphine place conditioning by the CCKA receptor antagonist devazepide.
    Higgins GA; Nguyen P; Sellers EM
    Eur J Pharmacol; 1991 May; 197(2-3):229-30. PubMed ID: 1915570
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholecystokinin inhibits food intake at a peripheral extragastric site.
    Zittel TT; Elm BV; Teichmann RK; Becker HD; Raybould HE
    Ann N Y Acad Sci; 1994 Mar; 713():431-4. PubMed ID: 8185211
    [No Abstract]   [Full Text] [Related]  

  • 7. "Gastrin" and "CCK" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa-II. Characterization by means of selective antagonists (L-364,718 and L-365,260).
    Roche S; Gusdinar T; Bali JP; Magous R
    Biochem Pharmacol; 1991 Jul; 42(4):771-6. PubMed ID: 1714276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of CCK on longitudinal and circular smooth muscle of chicken ileum. Mechanisms involved.
    Fernández E; Martín MT; Fernández AG; Goñalons E
    Ann N Y Acad Sci; 1994 Mar; 713():398-400. PubMed ID: 8185201
    [No Abstract]   [Full Text] [Related]  

  • 9. His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity.
    Jagerschmidt A; Guillaume-Rousselet N; Vikland ML; Goudreau N; Maigret B; Roques BP
    Eur J Pharmacol; 1996 Jan; 296(1):97-106. PubMed ID: 8720482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.
    Rataud J; Darche F; Piot O; Stutzmann JM; Böhme GA; Blanchard JC
    Brain Res; 1991 May; 548(1-2):315-7. PubMed ID: 1868342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260.
    Hill DR; Woodruff GN
    Brain Res; 1990 Sep; 526(2):276-83. PubMed ID: 2257485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCK antagonists and CCK-monoamine interactions in the control of satiety.
    Cooper SJ; Dourish CT; Clifton PG
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):291S-295S. PubMed ID: 1728842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-(Piperidin-2-yl)- and 5-(homopiperidin-2-yl)-1,4-benzodiazepines: high-affinity, basic ligands for the cholecystokinin-B receptor.
    Castro JL; Broughton HB; Russell MG; Rathbone D; Watt AP; Ball RG; Chapman KL; Patel S; Smith AJ; Marshall GR; Matassa VG
    J Med Chem; 1997 Aug; 40(16):2491-501. PubMed ID: 9258356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive and gastrointestinal transit effects of cholecystokinin (CCK-8) and related analogs of CCK-8 in the mouse.
    Ayres EA; Parkhurst DN; Fang S; Kramer TH; Hruby VJ; Burks TF
    Proc West Pharmacol Soc; 1991; 34():477-84. PubMed ID: 1788334
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of hypothalamic microinjection and ventricular perfusion of CCK receptor antagonists on gut myoelectrical activity.
    Nitecki S; Harty GJ; Szurszewski JH
    Ann N Y Acad Sci; 1994 Mar; 713():358-9. PubMed ID: 8185187
    [No Abstract]   [Full Text] [Related]  

  • 16. Cholecystokinin and morphine analgesia: variations on a theme.
    Stanfa L; Dickenson A; Xu XJ; Wiesenfeld-Hallin Z
    Trends Pharmacol Sci; 1994 Mar; 15(3):65-6. PubMed ID: 8184487
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible role of CCKB-receptors in anxiety: an "in vivo" study.
    Tessari M; Maraia G; Reggiani A
    Pharmacol Res; 1992; 25 Suppl 1():55-6. PubMed ID: 1508810
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin receptor antagonists.
    Zucker KA; Adrian TE; Modlin IM
    J Surg Res; 1988 Nov; 45(5):496-504. PubMed ID: 3054325
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of the cholecystokinin-B receptor antagonist L-365,260 on lactate-induced panic attacks in panic disorder patients.
    van Megen HJ; Westenberg HG; den Boer JA
    Biol Psychiatry; 1996 Oct; 40(8):804-6. PubMed ID: 8894076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.